CCL5 expression and tumor infiltrating immune cells in triple negative breast cancer.

被引:2
|
作者
Araujo, Jhajaira
Gomez, Andrea C.
Salgado, Roberto
Balko, Justin M.
Aguilar, Alfredo
Doimi, Franco
Morante, Zaida
Gomez, Henry
Pinto, Joseph A.
机构
[1] Oncosalud Auna, Lima, Peru
[2] Oncosalud AUNA, Unidad Investigac Basica Traslac, Lima, Peru
[3] Inst Jules Bordet, Brussels, Belgium
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
关键词
D O I
10.1200/JCO.2017.35.15_suppl.11553
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11553
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
    Araujo, Jhajaira M.
    Gomez, Andrea C.
    Aguilar, Alfredo
    Salgado, Roberto
    Balko, Justin M.
    Bravo, Leny
    Doimi, Franco
    Bretel, Denisse
    Morante, Zaida
    Flores, Claudio
    Gomez, Henry L.
    Pinto, Joseph A.
    SCIENTIFIC REPORTS, 2018, 8
  • [2] Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
    Jhajaira M. Araujo
    Andrea C. Gomez
    Alfredo Aguilar
    Roberto Salgado
    Justin M. Balko
    Leny Bravo
    Franco Doimi
    Denisse Bretel
    Zaida Morante
    Claudio Flores
    Henry L. Gomez
    Joseph A. Pinto
    Scientific Reports, 8
  • [3] Correlation between tumor infiltrating lymphocytes and CCL5 gene expression in chemotherapy-resistant triple negative breast cancer
    Pinto, Joseph A.
    Morante, Zaida D.
    Salgado, Roberto
    Cardenas, Nadezhda
    Araujo, Jhajaira
    Ponce, Jaime
    Doimi, Franco
    Balko, Justin
    Gomez, Henry
    CANCER RESEARCH, 2016, 76
  • [4] CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
    Dandan Lv
    Yan Zhang
    Ha-Jeong Kim
    Lixing Zhang
    Xiaojing Ma
    Cellular & Molecular Immunology, 2013, 10 : 303 - 310
  • [5] CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
    Lv, Dandan
    Zhang, Yan
    Kim, Ha-Jeong
    Zhang, Lixing
    Ma, Xiaojing
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (04) : 303 - 310
  • [6] Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
    Garcia-Teijido, Paula
    Luque Cabal, Maria
    Pelaez Fernandez, Ignacio
    Fernandez Perez, Yolanda
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 31 - 39
  • [7] The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment
    Augimeri, Giuseppina
    Fiorillo, Marco
    Morelli, Catia
    Panza, Salvatore
    Giordano, Cinzia
    Barone, Ines
    Catalano, Stefania
    Sisci, Diego
    Ando, Sebastiano
    Bonofiglio, Daniela
    CANCERS, 2023, 15 (03)
  • [8] Dynamic relationship between cycling kinetics of triple-negative breast cancer and tumor infiltrating immune cells
    Choudhary, Ishita
    Klimov, Sergey
    Rida, Padmashree C. G.
    Ogden, Angela
    Green, Andrew R.
    Aleskandarany, Mohammed A.
    Rakha, Emad A.
    Ellis, Ian O.
    Biganzoli, Elia
    Sarkar, Surojit
    Kalia, Vandana
    Aneja, Ritu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications
    Shan, Jingxuan
    Chouchane, Aziz
    Mokrab, Younes
    Saad, Mohamad
    Boujassoum, Salha
    Sayaman, Rosalyn W.
    Ziv, Elad
    Bouaouina, Noureddine
    Remadi, Yasmine
    Gabbouj, Sallouha
    Roelands, Jessica
    Ma, Xiaojing
    Bedognetti, Davide
    Chouchane, Lotfi
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] Triple-negative breast cancer displays a unique subset of macrophages dependent on CCL5 signaling
    Rabe, Daniel C.
    Frankenberger, Casey
    Bainer, Russell
    Gilad, Yoav
    Rosner, Marsha Rich
    CANCER RESEARCH, 2014, 74 (19)